Literature DB >> 18546342

Cerebellar ataxia as a possible organ-specific autoimmune disease.

Marios Hadjivassiliou1, Sabrina Boscolo, Enrico Tongiorgi, Richard A Grünewald, Basil Sharrack, David S Sanders, Nicola Woodroofe, G Aelwyn B Davies-Jones.   

Abstract

The purpose of this study was to investigate the possibility that autoimmunity is responsible for some cases of sporadic idiopathic ataxia. We prospectively investigated 400 patients with progressive ataxia and identified a group of patients with idiopathic sporadic ataxia. A comparison of the prevalence of autoimmune diseases, the autoimmunity linked HLA DQ2, and serum anticerebellar antibodies was made between patients with idiopathic sporadic and those with genetically characterized ataxia. Ninety-one of 400 (23%) patients with progressive ataxia had idiopathic sporadic ataxia. The prevalence of autoimmune diseases in this group was 47% as compared with 6% in the group of patients with genetic ataxias (P < 0.0001). The HLA DQ2 was found in 71% of patients with sporadic ataxia, in 34% in patients with genetic ataxia, and in 36% of healthy local population (P = 0.0005 by Chi squared test). Anticerebellar antibodies were detected in 12 out of 20 patients with idiopathic sporadic as opposed to one of 20 patients with genetic ataxia. The significantly higher prevalence of autoimmune diseases, HLA DQ2 and anti-cerebellar antibodies in patients with idiopathic sporadic ataxia compared to genetic ataxia supports the notion that autoimmunity may account for some cases of idiopathic sporadic cerebellar ataxia. Copyright 2008 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18546342     DOI: 10.1002/mds.22129

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  24 in total

1.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

2.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 3.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

4.  Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.

Authors:  Timotej Petrijan; Marija Menih
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

Review 5.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

6.  Cerebellar Ataxia With Extreme Photophobia Associated With Anti-SOX1 Antibodies.

Authors:  Lucas Alessandro; Daniel Schachter; Mauricio F Farez; Francisco Varela
Journal:  Neurohospitalist       Date:  2018-09-24

7.  Deep Brain Stimulation of the Interposed Nucleus Reverses Motor Deficits and Stimulates Production of Anti-inflammatory Cytokines in Ataxia Mice.

Authors:  Gajendra Kumar; Pallavi Asthana; Wing Ho Yung; Kin Ming Kwan; Chung Tin; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2022-05-17       Impact factor: 5.590

8.  'You don't get told anything, they don't do anything and nothing changes'. Medicine as a resource and constraint in progressive ataxia.

Authors:  Gavin Daker-White; Helen Kingston; Katherine Payne; Julie Greenfield; John Ealing; Caroline Sanders
Journal:  Health Expect       Date:  2012-10-24       Impact factor: 3.377

Review 9.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

10.  Late-onset sacsinopathy diagnosed by exome sequencing and comparative genomic hybridization.

Authors:  Angela Pyle; Helen Griffin; Jennifer Duff; Shona Bennett; Simon Zwolinski; Tania Smertenko; Patrick Yu-Wai Man; Mauro Santibanez-Koref; Rita Horvath; Patrick F Chinnery
Journal:  J Neurogenet       Date:  2013-11-04       Impact factor: 1.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.